CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ 2,419	$ 4,169	$ 4,202
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Transaction and credit losses	1,572	1,060	1,741
Depreciation and amortization	1,317	1,265	1,189
Stock-based compensation	1,261	1,376	1,376
Deferred income taxes	(811)	(482)	165
Net (gains) losses on strategic investments	304	(46)	(1,914)
Other	205	100	47
Changes in assets and liabilities:
Accounts receivable	(163)	(222)	(100)
Transaction loss allowance for cash losses, net	(1,230)	(1,178)	(1,120)
Other current assets and non-current assets	118	(486)	(171)
Accounts payable	(35)	(31)	(4)
Income taxes payable	373	73	(230)
Other current liabilities and non-current liabilities	483	199	1,038
Net cash provided by operating activities	5,813	5,797	6,219
Cash flows from investing activities:
Purchases of property and equipment	(706)	(908)	(866)
Proceeds from sales of property and equipment	5	5	120
Purchases and originations of loans receivable	(28,170)	(13,420)	(6,098)
Principal repayment of loans receivable	24,903	11,826	6,392
Purchases of investments	(20,219)	(40,116)	(41,513)
Maturities and sales of investments	23,411	39,698	30,908
Acquisitions, net of cash and restricted cash acquired	0	(2,763)	(3,609)
Funds receivable	(2,813)	193	(1,552)
Collateral posted related to derivative instruments, net	(19)	336	(327)
Other investing activities	187	0	0
Net cash used in investing activities	(3,421)	(5,149)	(16,545)
Cash flows from financing activities:
Proceeds from issuance of common stock	143	162	137
Purchases of treasury stock	(4,199)	(3,373)	(1,635)
Tax withholdings related to net share settlements of equity awards	(336)	(1,036)	(521)
Borrowings under financing arrangements	3,475	272	6,966
Repayments under financing arrangements	(1,686)	(361)	(3,000)
Funds payable and amounts due to customers	1,498	3,572	10,597
Collateral received related to derivative instruments, net	(6)	207	(38)
Other financing activities	1	0	(52)
Net cash (used in) provided by financing activities	(1,110)	(557)	12,454
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(155)	(102)	169
Net change in cash, cash equivalents, and restricted cash	1,127	(11)	2,297
Cash, cash equivalents, and restricted cash at beginning of period	18,029	18,040	15,743
Cash, cash equivalents, and restricted cash at end of period	19,156	18,029	18,040
Supplemental cash flow disclosures:
Cash paid for interest	280	231	190
Cash paid for income taxes, net	878	474	565
The table below reconciles cash, cash equivalents, and restricted cash as reported in the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:
Cash and cash equivalents	7,776	5,197	4,794
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	19,156	18,029	18,040
Short-term and long-term investments
The table below reconciles cash, cash equivalents, and restricted cash as reported in the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:
Restricted cash and cash equivalents	17	109	24
Funds receivable and customer accounts
The table below reconciles cash, cash equivalents, and restricted cash as reported in the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:
Restricted cash and cash equivalents	$ 11,363	$ 12,723	$ 13,222